537012 Sigma-AldrichProlyl Endopeptidase Inhibitor III, KYP-2047 - Calbiochem
The Prolyl Endopeptidase Inhibitor III, KYP-2047 controls the biological activity of Prolyl Endopeptidase. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.
More>> The Prolyl Endopeptidase Inhibitor III, KYP-2047 controls the biological activity of Prolyl Endopeptidase. This small molecule/inhibitor is primarily used for Protease Inhibitors applications. Less<<Synonyms: (S)-1-((S)-1-(4-phenylbutanoyl)-pyrrolidine-2-carbonyl)pyrrolidine-2-carbonitrile, 4-phenylbutanoyl-Lprolyl-2(S)-cyanopyrrolidine, PREP inhibitor III, KYP-2047
Recommended Products
Overview
Replacement Information |
---|
Key Specifications Table
Empirical Formula |
---|
C₂₀H₂₅N₃O₂ |
Products
Catalog Number | Packaging | Qty/Pack | |
---|---|---|---|
537012-5MG | Glass bottle | 5 mg |
Product Information | |
---|---|
Form | Clear, colorless oil |
Hill Formula | C₂₀H₂₅N₃O₂ |
Chemical formula | C₂₀H₂₅N₃O₂ |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Purity | ≥98% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Documentation
Prolyl Endopeptidase Inhibitor III, KYP-2047 - Calbiochem SDS
Title |
---|
Prolyl Endopeptidase Inhibitor III, KYP-2047 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
537012 |
References
Reference overview |
---|
Jarho, E., et al. 2004. J. Med. Chem. 47, 5605. Venalainen, J., et al. 2011. Biochem. Pharmacol. 71, 683. Jalkanen, A., et al. 2006. Basic & Clin. Pharmac. & Tox. 100, 132. Jalkanen, A., et al. 2011. Basic & Clin. Pharmac. & Tox. 109, 443. Klimaviciusa, L., et al. 2012. Journ. Neuros. Methods. 204, 104. Myohanen, T., et al. 2012. Brit. J. Pharm. 166, 1097. |